Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Cash from Financing Activities (2016 - 2026)

Myriad Genetics has reported Cash from Financing Activities over the past 17 years, most recently at -$8.2 million for Q4 2025.

  • Quarterly Cash from Financing Activities fell 490.48% to -$8.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.2 million through Dec 2025, up 967.57% year-over-year, with the annual reading at $64.2 million for FY2025, 967.57% up from the prior year.
  • Cash from Financing Activities was -$8.2 million for Q4 2025 at Myriad Genetics, down from $56.2 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $121.9 million in Q4 2023 and troughed at -$74.5 million in Q3 2021.
  • The 5-year median for Cash from Financing Activities is -$2.3 million (2022), against an average of $2.6 million.
  • Year-over-year, Cash from Financing Activities crashed 24350.0% in 2021 and then surged 5904.76% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.1 million in 2021, then tumbled by 90.91% to -$2.1 million in 2022, then surged by 5904.76% to $121.9 million in 2023, then tumbled by 98.28% to $2.1 million in 2024, then crashed by 490.48% to -$8.2 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Cash from Financing Activities are -$8.2 million (Q4 2025), $56.2 million (Q3 2025), and $2.6 million (Q2 2025).